NH - NantHealth, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Culver City,
United States
Type: Equity
NH price evolution
NH
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.64 | $5.71 | $16.08 | $29.08 |
| Short term investments | ||||
| Net receivables | $6.71 | $6.57 | $6.54 | $7.33 |
| Inventory | ||||
| Total current assets | $12.15 | $14.86 | $26.13 | $39.41 |
| Long term investments | ||||
| Property, plant & equipment | $16.36 | $17.1 | $17.63 | $18.41 |
| Goodwill & intangible assets | $130.68 | $132.91 | $135.14 | $137.37 |
| Total noncurrent assets | $148.76 | $152.02 | $155.28 | $158.42 |
| Total investments | ||||
| Total assets | $160.91 | $166.89 | $181.4 | $197.83 |
| Current liabilities | ||||
| Accounts payable | $11.04 | $7.76 | $9.59 | $8.37 |
| Deferred revenue | $4.06 | $4.08 | $4.5 | $4.46 |
| Short long term debt | $1.11 | $0.78 | ||
| Total current liabilities | $33.59 | $23.59 | $25.01 | $27.95 |
| Long term debt | $254.2 | $254.75 | $255.28 | $255.78 |
| Total noncurrent liabilities | $328.49 | $331.39 | $332.99 | $331.88 |
| Total debt | $255.31 | $254.75 | $255.28 | $256.57 |
| Total liabilities | $362.07 | $354.99 | $358 | $359.82 |
| Shareholders' equity | ||||
| Retained earnings | -$1095.02 | -$1081.36 | -$1068.85 | -$1052.9 |
| Other shareholder equity | -$0.91 | -$0.59 | -$0.31 | -$0.21 |
| Total shareholder equity | -$201.16 | -$188.1 | -$176.6 | -$161.99 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $29.08 | $22.79 | $5.24 | $18.3 |
| Short term investments | ||||
| Net receivables | $7.33 | $5.13 | $12.85 | $17.9 |
| Inventory | $0.8 | $0.5 | ||
| Total current assets | $39.41 | $30.59 | $37.91 | $39.44 |
| Long term investments | $31.7 | $40 | ||
| Property, plant & equipment | $18.41 | $20.64 | $26.17 | $22.98 |
| Goodwill & intangible assets | $137.37 | $146.3 | $167.78 | $180.63 |
| Total noncurrent assets | $158.42 | $169.69 | $228.57 | $246.89 |
| Total investments | $31.7 | $40 | ||
| Total assets | $197.83 | $200.29 | $266.49 | $286.34 |
| Current liabilities | ||||
| Accounts payable | $8.37 | $9.36 | $8.07 | $6.44 |
| Deferred revenue | $4.46 | $1.56 | $18.03 | $22.97 |
| Short long term debt | $0.78 | $100.26 | $0.24 | |
| Total current liabilities | $27.95 | $124.76 | $57.5 | $36.54 |
| Long term debt | $255.78 | $120.84 | $217.19 | $200.48 |
| Total noncurrent liabilities | $331.88 | $186.93 | $266.12 | $246.97 |
| Total debt | $256.57 | $221.09 | $217.43 | $200.48 |
| Total liabilities | $359.82 | $311.69 | $323.62 | $283.51 |
| Shareholders' equity | ||||
| Retained earnings | -$1052.9 | -$1003.21 | -$946.88 | -$884.12 |
| Other shareholder equity | -$0.21 | -$0.17 | -$0.22 | -$0.35 |
| Total shareholder equity | -$161.99 | -$111.78 | -$57.14 | $2.83 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $16.63 | $16.5 | $16.37 | $16.03 |
| Cost of revenue | $6.93 | $7.35 | $7.18 | $6.93 |
| Gross Profit | $9.71 | $9.15 | $9.19 | $9.1 |
| Operating activities | ||||
| Research & development | $6.3 | $5.86 | $5.71 | $5.2 |
| Selling, general & administrative | $16.58 | $14.02 | $14.98 | $14.78 |
| Total operating expenses | $23.86 | $20.86 | $21.68 | $20.97 |
| Operating income | -$14.16 | -$11.71 | -$12.49 | -$11.86 |
| Income from continuing operations | ||||
| EBIT | -$10.16 | -$9.07 | -$12.48 | -$13.09 |
| Income tax expense | -$0.01 | -$0.03 | $0.02 | $0.08 |
| Interest expense | $3.51 | $3.47 | $3.45 | $3.54 |
| Net income | ||||
| Net income | -$13.66 | -$12.51 | -$15.95 | -$16.7 |
| Income (for common shares) | -$13.66 | -$12.51 | -$15.95 | -$16.7 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $62.65 | $73.17 | $95.96 | $89.46 |
| Cost of revenue | $27.81 | $29.23 | $38.42 | $44.27 |
| Gross Profit | $34.84 | $43.95 | $57.54 | $45.2 |
| Operating activities | ||||
| Research & development | $19.71 | $17.27 | $19.07 | $20.92 |
| Selling, general & administrative | $52.09 | $48.53 | $61.04 | $70.76 |
| Total operating expenses | $75.74 | $70.21 | $88.31 | $95.9 |
| Operating income | -$40.9 | -$26.27 | -$30.77 | -$50.7 |
| Income from continuing operations | ||||
| EBIT | -$43.68 | -$36.68 | -$44.83 | -$178.71 |
| Income tax expense | $0.1 | $0.45 | -$0.11 | -$3.67 |
| Interest expense | $14.48 | $19.2 | $18.04 | $17.12 |
| Net income | ||||
| Net income | -$58.26 | -$56.33 | -$62.76 | -$192.15 |
| Income (for common shares) | -$58.26 | -$56.33 | -$62.76 | -$192.15 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$13.66 | -$12.51 | -$15.95 | -$16.7 |
| Operating activities | ||||
| Depreciation | $4.01 | $3.88 | $4.01 | $4.12 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.89 | $1.26 | $1.39 | $1.35 |
| Total cash flows from operations | -$5.02 | -$9.14 | -$11.05 | -$5.3 |
| Investing activities | ||||
| Capital expenditures | -$1.29 | -$1.66 | -$1.2 | -$0.96 |
| Investments | ||||
| Total cash flows from investing | -$1.29 | -$1.66 | -$1.2 | -$0.96 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.02 | $0.11 | ||
| Net borrowings | $1.11 | -$0.78 | -$10.28 | |
| Total cash flows from financing | $1.11 | -$0.76 | -$10.17 | |
| Effect of exchange rate | $0.13 | -$0.03 | -$0.05 | $0.01 |
| Change in cash and equivalents | -$5.08 | -$10.84 | -$13.06 | -$16.43 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | -$58.26 | -$56.33 | -$62.76 | -$192.15 |
| Operating activities | ||||
| Depreciation | $15.72 | $16.77 | $22.36 | $22.36 |
| Business acquisitions & disposals | $40.93 | $0.3 | $0.07 | |
| Stock-based compensation | $3.89 | $2.65 | $2.79 | $5.66 |
| Total cash flows from operations | -$27.69 | -$16.85 | -$8.77 | -$29.63 |
| Investing activities | ||||
| Capital expenditures | -$5.08 | -$5.67 | -$4.59 | -$10.55 |
| Investments | -$0.56 | |||
| Total cash flows from investing | -$5.64 | $35.25 | -$4.29 | -$10.48 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.29 | $0.17 | ||
| Net borrowings | $40.56 | $0.01 | $0.24 | -$0.09 |
| Total cash flows from financing | $40.58 | -$0.56 | -$0.03 | -$2.16 |
| Effect of exchange rate | -$0.01 | -$0.06 | $0.03 | -$0.3 |
| Change in cash and equivalents | $7.24 | $17.78 | -$13.06 | -$42.57 |
News
Fundamentals
| Market cap | $261.14M |
|---|---|
| Enterprise value | $515.82M |
| Shares outstanding | 115.55M |
| Revenue | $65.53M |
|---|---|
| EBITDA | -$28.77M |
| EBIT | -$44.80M |
| Net Income | -$58.82M |
| Revenue Q/Q | 15.84% |
| Revenue Y/Y | 0.42% |
| P/E ratio | -4.44 |
|---|---|
| EV/Sales | 7.87 |
| EV/EBITDA | -17.93 |
| EV/EBIT | -11.51 |
| P/S ratio | 3.98 |
| P/B ratio | -1.30 |
| Book/Share | -1.73 |
| Cash/Share | 0.01 |
| EPS | -$0.51 |
|---|---|
| ROA | -33.28% |
| ROE | 32.33% |
| Debt/Equity | -2.22 |
|---|---|
| Net debt/EBITDA | -12.57 |
| Current ratio | 0.36 |
| Quick ratio | 0.36 |